We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Investment Ideas feature highlights: Micron Technology, Nvidia, Tokyo Electron, CREE and Vishay Intertechnology
Read MoreHide Full Article
For Immediate Release
Chicago, IL – June 15, 2018 – Today, Zacks Investment Ideas feature highlights Features: Micron Technology (MU - Free Report) , Nvidia (NVDA - Free Report) , Tokyo Electron LTD (TOELY - Free Report) , CREE Inc and Vishay Intertechnology Inc (VSH - Free Report) .
Behind the Scenes in Semiconductors
The semiconductor industry has been red hot this year, up 16.5% as a whole versus 4% for the S&P 500. Top industry players like Micron Technology and Nvidia have gotten the lion’s share of the attention from investors – and rightfully so as they have performed even better than the industry.
If we consider the enormous scope of the industry and the vast number of products and manufacturing processes necessary to produce all the electronic products we use every single day, it makes sense to look deeper – for the smaller companies who make the products that underpin the semiconductor industry.
Tokyo Electron LTD produces semiconductor production equipment for a wide range of purposes including thermal processing, wafer preparation, corrective etching and, most notably, plasma etching used in the manufacture of flat-screen displays.
Founded in 1963, Tokyo Electron is rapidly growing sales, operating income and operating margins.
Expected to earn $3.81/share in 2018, an increase of 32% over 2017, Tokyo Electron is a Zacks Rank #2 (Buy) and also carries a VGM score of “A”, with the highest ranking possible in Value, Growth and Momentum.
Tokyo Electron also pays $1.27 in annual dividends – a 2.75% yield.
CREE Inc has primarily been known as an LED lighting company, thanks especially to its deal to sell branded light bulb in Home Depot stores, but it actually manufactures a wide range of semiconductor products that increase the energy efficiency and performance of numerous electronic devices.
Once a high flyer due to brand recognition of its innovative, money-saving lighting products, CREE shares suffered in 2015-2017 as the home LED market became saturated with low-priced competition and CREE lost market share. Recently CREE has refocused its efforts to include more products outside the consumer arena, including electronic signs, electric vehicles, renewable energy and radar and satellite communications.
Earnings estimates are rising again and CREE is expected to post a profit of $0.16/share in 2018, up 45% in the past 90 days. CREE is a Zacks Rank #2 (BUY).
Vishay Intertechnology Inc is one of the world’s largest manufacturers of discrete semiconductors and passive electronic components. Its products are used in the computing, automotive, telecommunications, military technology and medical industries, among others.
Diverse product offerings add up to consistently growing profits at VSH. The Zacks Composite Earnings Estimate for 20118 is $1.78/share, up from $1.57 60 days ago and a 25% increase over 2017.
Vishay is a Zacks Rank #1 (Strong Buy).
In a hot industry, it can sometimes be easy to focus on the household names in the space, but savvy investors should also seek out the lesser-known small companies that form the backbone of the sector for potentially explosive earnings and share price growth
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions. New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Investment Ideas feature highlights: Micron Technology, Nvidia, Tokyo Electron, CREE and Vishay Intertechnology
For Immediate Release
Chicago, IL – June 15, 2018 – Today, Zacks Investment Ideas feature highlights Features: Micron Technology (MU - Free Report) , Nvidia (NVDA - Free Report) , Tokyo Electron LTD (TOELY - Free Report) , CREE Inc and Vishay Intertechnology Inc (VSH - Free Report) .
Behind the Scenes in Semiconductors
The semiconductor industry has been red hot this year, up 16.5% as a whole versus 4% for the S&P 500. Top industry players like Micron Technology and Nvidia have gotten the lion’s share of the attention from investors – and rightfully so as they have performed even better than the industry.
If we consider the enormous scope of the industry and the vast number of products and manufacturing processes necessary to produce all the electronic products we use every single day, it makes sense to look deeper – for the smaller companies who make the products that underpin the semiconductor industry.
Tokyo Electron LTD produces semiconductor production equipment for a wide range of purposes including thermal processing, wafer preparation, corrective etching and, most notably, plasma etching used in the manufacture of flat-screen displays.
Founded in 1963, Tokyo Electron is rapidly growing sales, operating income and operating margins.
Expected to earn $3.81/share in 2018, an increase of 32% over 2017, Tokyo Electron is a Zacks Rank #2 (Buy) and also carries a VGM score of “A”, with the highest ranking possible in Value, Growth and Momentum.
Tokyo Electron also pays $1.27 in annual dividends – a 2.75% yield.
CREE Inc has primarily been known as an LED lighting company, thanks especially to its deal to sell branded light bulb in Home Depot stores, but it actually manufactures a wide range of semiconductor products that increase the energy efficiency and performance of numerous electronic devices.
Once a high flyer due to brand recognition of its innovative, money-saving lighting products, CREE shares suffered in 2015-2017 as the home LED market became saturated with low-priced competition and CREE lost market share. Recently CREE has refocused its efforts to include more products outside the consumer arena, including electronic signs, electric vehicles, renewable energy and radar and satellite communications.
Earnings estimates are rising again and CREE is expected to post a profit of $0.16/share in 2018, up 45% in the past 90 days. CREE is a Zacks Rank #2 (BUY).
Vishay Intertechnology Inc is one of the world’s largest manufacturers of discrete semiconductors and passive electronic components. Its products are used in the computing, automotive, telecommunications, military technology and medical industries, among others.
Diverse product offerings add up to consistently growing profits at VSH. The Zacks Composite Earnings Estimate for 20118 is $1.78/share, up from $1.57 60 days ago and a 25% increase over 2017.
Vishay is a Zacks Rank #1 (Strong Buy).
In a hot industry, it can sometimes be easy to focus on the household names in the space, but savvy investors should also seek out the lesser-known small companies that form the backbone of the sector for potentially explosive earnings and share price growth
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions. New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Follow us on Twitter: https://twitter.com/ZacksResearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.